The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Making the most of retirement involves embracing new experiences and opportunities. Uncover ways to enhance your retirement life.
19,809 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
In a market eager for AI breakthroughs, one tech stock with eyes stands out as a long-term buy. This article breaks d...
A top economist says wage gains aren’t keeping up with inflation, leaving Americans literally getting squeezed as hou...
What would it take for the next company to reach a $5 trillion market cap? This article breaks down the path, the can...
Full-time hospital dogs are helping seriously ill children smile and move again, as programs expand nationwide and do...
Nvidia stunned the market with strong earnings, yet the stock fell. This article explains why the drop happened, what...
SpaceX could redefine aerospace and energy, but investing in Elon Musk-backed ventures is no simple bet. This guide u...
Turnaround stories can create powerful upside for patient investors, but they also open doors for short sellers who b...
When Apple speaks at WWDC, markets listen. This article breaks down how Apple Just Delivered News about AI strategy, ...
Bitcoin has clawed back from the $60,000 zone and sits near $65,000 as markets brace for the Federal Reserve’s policy...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
The private credit boom faces a real test as higher rates and shifting liquidity tighten the lending landscape. This ...